ArticleFrontiers in clinical diabetes and healthcare2026
Incidence and outcomes of diabetes mellitus amongst hospital admissions with
Article in Frontiers in clinical diabetes and healthcare, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diabetes Mellitus (DM) is a recognized risk factor for the development of acute and chronic heart failure (HF). Methods: This retrospective cohort study was conducted at the largest advanced HF center in Qatar. All patients admitted with DNHF were grouped as: 1) newly diagnosed DM, 2) pre-existing DM, 3) prediabetes, and 4) no DM. Clinical characteristics and in-hospital/post-discharge outcomes were described. Continuous variables were reported as mean with standard deviation or IQR and categorical variables as frequency distribution with percentage. Results: Among 260 patients with DNHF, 173 (66.5%) had DM, and 52 (20%) were prediabetic. Newly diagnosed DM was identified in 26 (10%), 147 (56.5%) were known diabetics. Compared with known DM, newly diagnosed patients were predominantly male (92.3% Conclusion: Our findings indicate the high burden of dysglycemia (DM and prediabetes) that is present in DNHF patients. Furthermore, DNHF served as the initial clinical presentation of DM or prediabetes in approximately one-third of our patients. This underscores the need for routine metabolic screening in patients presenting with DNHF, as early identification and management of DM is crucial in this population to improve outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.